TENAX THERAPEUTICS, INC. Business Finance Contracts & Agreements
109 Contracts & Agreements
- Assignment Agreements (1 contract)
- Note Agreements (4)
- Purchase Agreements (18)
- Registration Rights Agreements (5)
- Stock Agreements (29)
- Subscription Agreements (2)
- Term Sheets (1)
- Underwriting Agreements (2)
- Waiver Agreements (1)
- Warrant Agreements (46)
- Form of Registration Rights Agreement (Filed With SEC on August 6, 2024)
- Form of Securities Purchase Agreement, dated August 6, 2024, by and among Tenax Therapeutics, Inc. and the investors signatory thereto (Filed With SEC on August 6, 2024)
- Form of Warrant to Purchase Shares of Common Stock or Pre-Funded Warrants (Filed With SEC on August 6, 2024)
- Form of Pre-Funded Warrant to Purchase Common Stock (Filed With SEC on August 6, 2024)
- Description of Common Stock (Filed With SEC on March 28, 2024)
- Form of Securities Purchase Agreement by and between Tenax Therapeutics, Inc. and the purchasers named therein (Filed With SEC on February 12, 2024)
- Form of Common Stock Purchase Warrant (Filed With SEC on February 12, 2024)
- Form of Pre-Funded Common Stock Purchase Warrant (Filed With SEC on February 12, 2024)
- Warrant Agency Agreement, dated as of February 12, 2024, by and between Tenax Therapeutics, Inc. and Direct Transfer LLC (Filed With SEC on February 12, 2024)
- Form of Securities Purchase Agreement (Filed With SEC on February 1, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on February 1, 2024)
- Form of Common Stock Purchase Warrant (Filed With SEC on February 1, 2024)
- Form of Warrant Agency Agreement (Filed With SEC on February 1, 2024)
- Form of Securities Purchase Agreement by and between Tenax Therapeutics, Inc. and the purchasers named therein (Filed With SEC on February 7, 2023)
- Form of Common Stock Purchase Warrant (Filed With SEC on February 7, 2023)
- Form of Pre-Funded Common Stock Purchase Warrant (Filed With SEC on February 7, 2023)
- Warrant Agency Agreement, dated as of February 3, 2023, by and between Tenax Therapeutics, Inc. and Direct Transfer LLC (Filed With SEC on February 7, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on January 31, 2023)
- Form of Pre-Funded Warrant (Filed With SEC on January 31, 2023)
- Form of Warrant (Filed With SEC on January 31, 2023)
- Form of Warrant Agency Agreement (Filed With SEC on January 31, 2023)
- Waiver dated June 13, 2022 (Filed With SEC on June 16, 2022)
- Form of Tenax Therapeutics, Inc. Notice of Stock Option Grant and Award Agreement (Filed With SEC on June 10, 2022)
- Registration Rights Agreement, dated as of May 17, 2022, by and between the Company and the Investor (Filed With SEC on May 20, 2022)
- Securities Purchase Agreement for Units, dated as of May 17, 2022, by and between the Company and the Investor (Filed With SEC on May 20, 2022)
- Warrant Amendment Agreement, dated as of May 17, 2022, by and between the Company and the Investor (Filed With SEC on May 20, 2022)
- Form of Series E Common Stock Warrant (2022) (Filed With SEC on May 20, 2022)
- Form of Pre-Funded Warrant (2022) (Filed With SEC on May 20, 2022)
- Description of Common Stock (Filed With SEC on March 29, 2022)
- Plan for Employee Inducement Stock Options adopted July 6, 2021 with Form of Stock Option Agreement (Filed With SEC on July 8, 2021)
- Registration Rights Agreement dated as of July 6, 2021 by and between the Company and the Investor (Filed With SEC on July 8, 2021)
- Securities Purchase Agreement for Unregistered Pre-Funded Warrant, dated as of July 6, 2021 by and between the Company and the Investor (Filed With SEC on July 8, 2021)
- Form of HCW Warrant (2021) (Filed With SEC on July 8, 2021)
- Form of Unregistered Warrant (2021) (Filed With SEC on July 8, 2021)
- Form of Unregistered Pre-Funded Warrant (2021) (Filed With SEC on July 8, 2021)
- Description of Common Stock (Filed With SEC on March 31, 2021)
- Certificate of Designation of Series B Convertible Preferred Stock (Filed With SEC on January 19, 2021)
- Form of Registration Rights Agreement, dated as of July 6, 2020, by and between the Company and the Investor (Filed With SEC on July 8, 2020)
- Form of Securities Purchase Agreement for Class E Units and Class F Units, dated as of July 6, 2020, by and between the Company and the Investor (Filed With SEC on July 8, 2020)
- Form of Securities Purchase Agreement for Class C Units and Class D Units, dated as of July 6, 2020, by and between the Company and the Investor (Filed With SEC on July 8, 2020)
